254 related articles for article (PubMed ID: 15743104)
1. Optimizing gonadotropin-releasing hormone agonist therapy in women with endometriosis.
Olive DL
Treat Endocrinol; 2004; 3(2):83-9. PubMed ID: 15743104
[TBL] [Abstract][Full Text] [Related]
2. Add-back therapy in the treatment of endometriosis-associated pain.
Zupi E; Marconi D; Sbracia M; Zullo F; De Vivo B; Exacustos C; Sorrenti G
Fertil Steril; 2004 Nov; 82(5):1303-8. PubMed ID: 15533351
[TBL] [Abstract][Full Text] [Related]
3. The role of add-back therapy in the United States.
Olive DL
Drugs Today (Barc); 2005 Jul; 41 Suppl A():23-6. PubMed ID: 16200222
[TBL] [Abstract][Full Text] [Related]
4. [The role of the combined balneotherapeutic treatment as the 'add-back therapy' against the background of the anti-hormonal effects of the agonists of gonadotropin-releasing hormone in the women suffering from endometriosis genitalis externa].
Akhkubekova NK; Kaysinova AS; Fedorov AA; Efimenko NB; Gaidamaka II; Chalaja EN; Cherevashchenko LA; Tsallagova LV; Urvacheva EE; Ovsienko AB
Vopr Kurortol Fizioter Lech Fiz Kult; 2018; 95(5):31-39. PubMed ID: 30412147
[TBL] [Abstract][Full Text] [Related]
5. [Clinical efficacy and safety of gonadotropin releasing hormone agonist combined with estrogen-dydrogesteronea in treatment of endometriosis].
Long QQ; Zhang SF; Han Y; Chen H; Li XL; Hua KQ; Hu WG
Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):247-51. PubMed ID: 20646533
[TBL] [Abstract][Full Text] [Related]
6. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
[TBL] [Abstract][Full Text] [Related]
7. Low-dose add-back therapy during postoperative GnRH agonist treatment.
Tsai HW; Wang PH; Huang BS; Twu NF; Yen MS; Chen YJ
Taiwan J Obstet Gynecol; 2016 Feb; 55(1):55-9. PubMed ID: 26927249
[TBL] [Abstract][Full Text] [Related]
8. Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? Add-Back Consensus Working Group.
Surrey ES
Fertil Steril; 1999 Mar; 71(3):420-4. PubMed ID: 10065775
[TBL] [Abstract][Full Text] [Related]
9. Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy.
Surrey ES; Voigt B; Fournet N; Judd HL
Fertil Steril; 1995 Apr; 63(4):747-55. PubMed ID: 7890057
[TBL] [Abstract][Full Text] [Related]
10. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
[TBL] [Abstract][Full Text] [Related]
11. Results of insemination (AIH) following GnRH treatment of endometriosis.
Keresztúri A; Szöllosi J; Daru J; Koloszár S; Pál A
Arch Androl; 2002; 48(4):243-9. PubMed ID: 12137584
[TBL] [Abstract][Full Text] [Related]
12. Current approaches to optimizing the treatment of endometriosis in adolescents.
Laufer MR
Gynecol Obstet Invest; 2008; 66 Suppl 1():19-27. PubMed ID: 18936548
[TBL] [Abstract][Full Text] [Related]
13. Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome.
Mitwally MF; Gotlieb L; Casper RF
Menopause; 2002; 9(4):236-41. PubMed ID: 12082359
[TBL] [Abstract][Full Text] [Related]
14. Conventional medical therapies for endometriosis.
Rice VM
Ann N Y Acad Sci; 2002 Mar; 955():343-52; discussion 389-93, 396-406. PubMed ID: 11949960
[TBL] [Abstract][Full Text] [Related]
15. Delayed oral estradiol combined with leuprolide increases endometriosis-related pain.
Hurst BS; Gardner SC; Tucker KE; Awoniyi CA; Schlaff WD
JSLS; 2000; 4(2):97-101. PubMed ID: 10917114
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis.
Wu D; Hu M; Hong L; Hong S; Ding W; Min J; Fang G; Guo W
Arch Gynecol Obstet; 2014 Sep; 290(3):513-23. PubMed ID: 24728145
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.
Taylor HS; Giudice LC; Lessey BA; Abrao MS; Kotarski J; Archer DF; Diamond MP; Surrey E; Johnson NP; Watts NB; Gallagher JC; Simon JA; Carr BR; Dmowski WP; Leyland N; Rowan JP; Duan WR; Ng J; Schwefel B; Thomas JW; Jain RI; Chwalisz K
N Engl J Med; 2017 Jul; 377(1):28-40. PubMed ID: 28525302
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?
Surrey ES
Curr Opin Obstet Gynecol; 2010 Aug; 22(4):283-8. PubMed ID: 20498596
[TBL] [Abstract][Full Text] [Related]
19. The role of GnRH agonists plus add-back therapy in the treatment of endometriosis.
Gargiulo AR; Hornstein MD
Semin Reprod Endocrinol; 1997; 15(3):273-84. PubMed ID: 9383836
[TBL] [Abstract][Full Text] [Related]
20. Update on the management of endometriosis-associated pain in France.
Fernandez H; Agostini A; Baffet H; Chabbert-Buffet N; Descamps P; Estrade JP; Giraudet G; Hocke C; Salle B; Tremollieres F; Chapron C
J Gynecol Obstet Hum Reprod; 2023 Nov; 52(9):102664. PubMed ID: 37669732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
